SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-064194
Filing Date
2010-12-01
Accepted
2010-12-01 07:10:54
Documents
6
Period of Report
2010-12-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v204328_8k.htm 8-K 38593
2 v204328_ex99-1.htm EX-99.1 26888
3 GRAPHIC ex99-1logo.jpg GRAPHIC 7675
4 v204328_ex99-2.htm EX-99.2 1502532
5 v204328_ex99-3.htm EX-99.3 43736
6 GRAPHIC ex99-3sig.jpg GRAPHIC 10879
  Complete submission text file 0001144204-10-064194.txt   1639209
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 101223518
SIC: 2836 Biological Products, (No Diagnostic Substances)